The First Affiliated Hospital, Zhejiang University School of Medicine
Zhejiang University's flagship academic medical center, recognised for organ transplantation, hematology, hepatobiliary and gastrointestinal cancer care, and complex multidisciplinary treatment for patients who need more than routine oncology.
About The First Affiliated Hospital, Zhejiang University School of Medicine
The First Affiliated Hospital, Zhejiang University School of Medicine, commonly known as FAHZU, is one of China's leading public academic medical centers, located in Hangzhou in Zhejiang Province. Founded in 1947 by Mr. Zhu Kezhen, the then-Headmaster of Zhejiang University, FAHZU is the earliest affiliated hospital of the university and has developed into a large tertiary general hospital integrating medical care, education, research, prevention, rehabilitation, and international healthcare services. The hospital operates seven campuses, has nearly 5,000 inpatient beds and more than 11,000 staff members, and recorded over 9.38 million outpatient and emergency visits along with 395,000 inpatient discharges in 2024.
FAHZU is especially recognised for complex disease management, organ transplantation, hematology and bone marrow transplantation, infectious diseases, gastroenterology, hepatobiliary and pancreatic surgery, gastrointestinal and colorectal surgery, medical oncology, radiation oncology, nephrology, urology, and critical care medicine. The hospital has 2 national key disciplines and 28 national clinical key specialties, with gastroenterology ranked first nationwide in the 2023 China Hospital Science and Technology Evaluation Metrics report by the Chinese Academy of Medical Sciences. For cancer patients, FAHZU is particularly valuable when the disease is complicated by liver dysfunction, severe infection, transplant consideration, hematologic involvement, or the need for true multidisciplinary review.
FAHZU has been rated A++ in China's national performance evaluation of tertiary public hospitals for six consecutive years and ranks within the national top 1% among 1,588 tertiary general public hospitals assessed. The hospital is building a National Medical Center and a National Medical Center for Infectious Diseases, and houses the NHCPRC Key Laboratory of Combined Multi-organ Transplantation. With 54,500 square meters of research facilities, 1,226 full-time research staff, and academic partnerships with institutions including Stanford University, Johns Hopkins Hospital, the University of Pittsburgh, Charité Medical Center and Kyoto University, FAHZU combines clinical depth with translational research capacity. Its scientific output appears in journals including Nature, Cell, Science, The New England Journal of Medicine and The Lancet.
CancerFax works directly with FAHZU's International Healthcare Center to help patients from outside China access the hospital's specialist oncology, hematology and transplant programmes. From submitting medical records and obtaining a clinical opinion to coordinating visa documentation, appointments and in-hospital interpretation, CancerFax manages the entire navigation process at no cost to the patient, so that those who need FAHZU's complex multidisciplinary care can reach it without logistical or language barriers.
| Hospital at a Glance | |
|---|---|
| Country | China |
| City | Hangzhou, Zhejiang Province |
| Established | 1947 |
| Hospital Type | Public Tertiary Academic Medical Center · National Medical Center |
| Accreditation | A++ National Tertiary Hospital Performance Rating (6 consecutive years) · Top 1% Nationally · Zhejiang University Teaching Hospital |
| Beds | ~5,000 inpatient beds across 7 campuses |
| Annual Patient Volume | 9.38M+ outpatient and emergency visits; 395,000+ inpatient discharges (2024) |
| Research Focus | Organ transplantation, infectious diseases, hematology, gastroenterology, hepatobiliary cancer, gastrointestinal cancer, precision oncology |
Why Patients Choose FAHZU
FAHZU is built for patients whose cancer or complex disease needs more than a single specialty. Its A++ academic standing combines deep oncology expertise with national-level strength in transplant, infectious disease and critical care, all under one institution.
Cancer Specialties and Clinical Departments
FAHZU manages cancer through deeply integrated departments rather than as a standalone cancer hospital, which is particularly useful for patients whose disease overlaps with liver, gastrointestinal, hematologic, transplant, infectious or critical care needs.
Advanced Treatment Capabilities
Key Specialists at FAHZU
FAHZU is staffed by more than 11,000 employees, including 443 senior specialists and 675 associate senior specialists, organised into a wide network of clinical, surgical and diagnostic departments. Cancer care is delivered through a true multidisciplinary model, with case discussions drawing together medical oncology, radiation oncology, hematology, hepatobiliary and pancreatic surgery, gastrointestinal surgery, colorectal surgery, breast surgery, transplant medicine, infectious diseases, radiology, nuclear medicine, pathology, clinical pharmacy and critical care under a single academic framework.
FAHZU is the earliest teaching hospital of Zhejiang University School of Medicine, and many senior physicians hold concurrent academic, research and training roles. The hospital has established international relationships with more than 30 leading institutions including Stanford University, Johns Hopkins Hospital, the University of Pittsburgh, Charité Medical Center and Kyoto University. Patients seeking a consultation with a specific physician or a multidisciplinary second opinion may submit their request through the CancerFax coordination process before confirming travel, and CancerFax will work with the International Healthcare Center to match the case to the most relevant department.
Patients seeking specific physician consultations or second opinions may request a review through the CancerFax coordination process before confirming travel or admission.
Clinical Infrastructure and Treatment Technology
FAHZU's seven-campus network combines hospital-grade clinical care with research-grade infrastructure, including advanced imaging, robotic surgery, intelligent logistics and a 20,000 square meter International Healthcare Center designed for complex inpatient management.
- Zhejiang Province's first PET/MR imaging system for high-precision tumour characterisation
- 3.0T MRI, CT, low-dose CT and PET-CT for staging and treatment response assessment
- Dedicated radiology and nuclear medicine departments with English imaging reports for international patients
- Fourth-generation Da Vinci surgical robot for precision minimally invasive oncology surgery
- Advanced gastroscopy and colonoscopy endoscopy center for GI cancer diagnosis and intervention
- Hepatobiliary, pancreatic, gastrointestinal, colorectal and breast surgical oncology programmes
- NHCPRC Key Laboratory of Combined Multi-organ Transplantation, established 2000 at FAHZU
- Bone Marrow Transplantation Center for leukemia, lymphoma, myeloma and bone marrow failure
- Integrated infectious disease, ICU and clinical pharmacy support for immunocompromised patients
- Comprehensive laboratory medicine and pathology services with molecular diagnostic capability
- 54,500 sqm of dedicated research facilities and 1,226 full-time research staff
- Active national research programmes and publications in Nature, NEJM, Lancet, Cell and Science
International Patient Support at FAHZU
FAHZU's International Healthcare Center is an independent ~20,000 square meter facility on the main campus, providing end-to-end coordinated services for international and high-end patients, from outpatient consultation through advanced diagnostics to inpatient care in private single suites.
What to Prepare Before Traveling
- arrow_rightShare all pathology reports, biopsy slides, imaging (CT, PET-CT, MRI, ultrasound), molecular testing and prior treatment summaries in English at least one week before your appointment, so that the FAHZU team can review eligibility for surgery, transplant evaluation, systemic therapy or multidisciplinary review in advance.
- arrow_rightObtain a Medical Visa (S2) for China; the International Healthcare Center can issue an official hospital invitation letter through CancerFax to support your application at the Chinese embassy in your home country.
- arrow_rightPlan travel to Hangzhou and confirm which FAHZU campus you are visiting; the International Healthcare Center is located in Building 1, 1367 Wenyi West Road, Yuhang District, and the main Qingchun Campus is at 79 Qingchun Road, Shangcheng District.
To contact FAHZU's International Healthcare Center directly, call +86 571 87234455 or email [email protected] (Monday to Friday, 08:00 to 12:00 and 13:30 to 17:00 CST). CancerFax coordinates all communication with the international desk on your behalf at no cost to the patient.
Patient Facilities and Accommodation at FAHZU
FAHZU's main campuses combine modern inpatient towers with an independent International Healthcare Center designed around private suites, advanced diagnostics and coordinated patient-centered care.
Family members accompanying international patients are advised to book accommodation near the relevant FAHZU campus, either Yuhang District (Headquarters campus) or Shangcheng District (Qingchun Campus); the International Healthcare Center can recommend nearby hotels and assist with logistics.
How to Reach FAHZU
FAHZU operates multiple campuses across Hangzhou, the capital of Zhejiang Province, approximately 30 minutes to one hour by car from Hangzhou Xiaoshan International Airport, with strong metro and highway connections across the city.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
FAHZU — Patient Questions Answered
CancerFax acts as your personal coordinator throughout the entire process of accessing FAHZU. You start by sharing your medical records, including pathology, imaging, molecular testing and prior treatment history, through our secure platform. Our clinical team reviews your case carefully and assesses which FAHZU department is most relevant for your diagnosis, whether that is medical oncology, hematology, hepatobiliary surgery, gastrointestinal surgery, transplant medicine, infectious diseases or radiation oncology. We then submit your case directly to FAHZU's International Healthcare Center and work with their team to confirm the right specialist and appointment slot.
Once your consultation is confirmed, CancerFax prepares a full pre-travel briefing covering expected costs, visa documentation, transport to the correct FAHZU campus and what to bring on the day. We stay as your single point of contact from first enquiry through to consultation and follow-up. CancerFax does not charge patients for this service and adds no mark-up on hospital fees. Our role is to remove every barrier between you and the treatment review you need.
FAHZU's deepest oncology strengths sit at the intersection of cancer and complex organ disease. The hospital is particularly relevant for liver cancer (including cases requiring transplant evaluation), gastric cancer, colorectal cancer, pancreatic cancer, cholangiocarcinoma, esophageal cancer, lung cancer and breast cancer, supported by departments that rank among China's best in gastroenterology and hepatobiliary surgery. On the hematology side, FAHZU manages leukemia, lymphoma, multiple myeloma and bone marrow failure syndromes through its dedicated Bone Marrow Transplantation Center. If your diagnosis is unclear or sits outside these areas, share your records with CancerFax and we will confirm suitability before any travel is planned.
Yes, FAHZU is one of China's leading centers for liver disease and is recognised as one of the country's most comprehensive medical centers for major organ transplantation. It hosts the NHCPRC Key Laboratory of Combined Multi-organ Transplantation, with strong integrated capability across hepatobiliary and pancreatic surgery, medical oncology, radiology, pathology, infectious diseases and ICU. This makes FAHZU especially appropriate for patients with hepatocellular carcinoma, cholangiocarcinoma or end-stage liver disease who need surgical evaluation, transplant assessment or combined treatment planning. CancerFax can help submit your imaging, liver function tests and pathology reports for a preliminary opinion from FAHZU's hepatobiliary team before you commit to travel.
Yes. FAHZU's International Healthcare Center can review medical records and provide a specialist opinion remotely before a patient commits to travel. The process typically involves submitting CT, MRI, PET-CT and ultrasound reports, pathology and IHC reports, molecular testing where available, surgical and discharge summaries, and a current medication list, ideally translated into English. CancerFax handles this submission and follows up with the relevant department on your behalf to obtain a written opinion or preliminary treatment recommendation, usually within one to two weeks depending on the complexity of the case. This is particularly useful for patients considering complex surgery, transplant evaluation or multidisciplinary review.
Consultation fees at FAHZU are generally more affordable than comparable specialist academic centers in North America, Europe or the Gulf, though exact costs vary by specialist seniority, department and whether diagnostic tests are performed on the same visit. For complex cases involving multidisciplinary review, transplant evaluation or advanced imaging like PET/MR, additional diagnostic fees are typically quoted separately. CancerFax requests an itemised cost estimate from FAHZU's International Healthcare Center as part of the pre-travel package, provided to you free of charge before you confirm the appointment. We do not add any mark-up on hospital fees. If you carry international health insurance, FAHZU supports direct billing for selected commercial plans, and we can advise on the documentation required.
Send Your Medical Reports for a Free Review
CancerFax reviews your records and coordinates your consultation at The First Affiliated Hospital, Zhejiang University School of Medicine, one of China's leading academic medical centers for complex cancer, transplant and hematology care. No cost, no obligation, and complete confidentiality.